Is pembrolizumab monotherapy the optimal treatment for elderly patients with PD-L1 positive advanced non-small cell lung cancer?

Ann Transl Med. 2020 Jun;8(12):778. doi: 10.21037/atm.2020.02.68.

Authors

Fiona Mienko¹, Balazs Halmos¹, Haiying Cheng¹

Affiliation

¹ Department of Medical Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY, USA.

No abstract available

Publication types

Editorial
Comment